S100A8 and neoplasm: RNA-Seq of bulk tumor samples verified an enrichment of neutrophil-derived genes in combination-treated tumors, specifically, genes associated with pathological activation of neutrophils and MDSC-mediated suppressive function, such as S100a8/a9, Mmp9, and Arg1.